Citation: G. Barosi et al., COST-EFFECTIVENESS OF RECOMBINANT-HUMAN-ERYTHROPOIETIN IN THE PREVENTION OF CHEMOTHERAPY-INDUCED ANEMIA, British Journal of Cancer, 78(6), 1998, pp. 781-787
Citation: Nl. Liberato et al., COST-EFFECTIVENESS OF INTERFERON-ALFA IN CHRONIC MYELOGENOUS LEUKEMIA, Journal of clinical oncology, 15(7), 1997, pp. 2673-2682
Authors:
LIBERATO NL
QUAGLINI S
BELLAZZI R
GUARNONE R
BAROSI G
Citation: Nl. Liberato et al., ALPHA-INTERFERON VERSUS HYDROXYUREA IN CHRONIC MYELOID-LEUKEMIA - A COST-EFFECTIVENESS ANALYSIS, Blood, 86(10), 1995, pp. 3175-3175
Authors:
BORGNAPIGNATTI C
LIBERATO NL
MARRADI P
ROSTI V
BAROSI G
Citation: C. Borgnapignatti et al., REGULATION OF ERYTHROPOIETIN PRODUCTION IN A CASE OF CONGENITAL ERYTHROPOIETIN-DEPENDENT PURE ERYTHROCYTOSIS, American journal of hematology, 46(4), 1994, pp. 348-353
Authors:
GALANELLO R
BARELLA S
TURCO MP
GIAGU N
CAO A
DORE F
LIBERATO NL
GUARNONE R
BAROSI G
Citation: R. Galanello et al., SERUM ERYTHROPOIETIN AND ERYTHROPOIESIS IN HIGH-FETAL AND LOW-FETAL HEMOGLOBIN BETA-THALASSEMIA-INTERMEDIA PATIENTS, Blood, 83(2), 1994, pp. 561-565
Authors:
BAROSI G
MERLO C
PALESTRA P
LIBERATO NL
GUARNONE R
DIDIO F
PIAZZA V
SALVADEO A
Citation: G. Barosi et al., VARIATIONS IN ERYTHROPOIESIS AND SERUM FERRITIN DURING ERYTHROPOIETINTHERAPY FOR ANEMIA OF END-STAGE RENAL-DISEASE, Acta haematologica, 90(1), 1993, pp. 13-18